Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
about
Role of periostin and its antagonist PNDA-3 in gastric cancer metastasisSuperior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsMonoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists.EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaTrends in therapeutic monoclonal antibodies of cancer.Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.
P2860
Q28088349-74EA021C-3520-4061-8DE8-CDF5867F5C3AQ35868868-B48EE524-7241-42C9-86E4-E5EDE010C3E6Q36715285-98CF17A0-9FD8-4B18-BB2E-0A01B7832D5AQ36883843-25C6632C-9148-4514-BB77-63878F13FCCCQ37066113-917DC3EA-5A09-4359-A0CC-1EBFC4F73CF1Q37329160-1967ADE4-51E7-49F1-89C1-188684935190Q37689796-F2388955-206D-408F-B255-D187D90E52E1Q39110485-76A62CD8-E0E8-4030-967C-1C56CB691CCE
P2860
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@ast
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@en
type
label
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@ast
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@en
prefLabel
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@ast
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@en
P2860
P356
P1433
P1476
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
@en
P2093
Uwe Zangemeister-Wittke
P2860
P304
P356
10.1159/000091325
P577
2005-01-01T00:00:00Z